Your browser doesn't support javascript.
loading
Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.
Vittorio, Serena; Dank, Christian; Ielo, Laura.
Afiliación
  • Vittorio S; Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Via Mangiagalli, 25, 20133 Milano, Italy.
  • Dank C; Institute of Organic Chemistry, University of Vienna, Währinger Strasse 38, 1090 Vienna, Austria.
  • Ielo L; Department of Chemistry, University of Turin, Via P. Giuria 7, 10125 Torino, Italy.
Int J Mol Sci ; 24(10)2023 May 22.
Article en En | MEDLINE | ID: mdl-37240442
ABSTRACT
Tyrosinase is a copper-containing enzyme which is widely distributed in nature (e.g., bacteria, mammals, fungi) and involved in two consecutive steps of melanin biosynthesis. In humans, an excessive production of melanin can determine hyperpigmentation disorders as well as neurodegenerative processes in Parkinson's disease. The development of molecules able to inhibit the high activity of the enzyme remain a current topic in medicinal chemistry, because the inhibitors reported so far present several side effects. Heterocycle-bearing molecules are largely diffuse in this sense. Due to their importance as biologically active compounds, we decided to report a comprehensive review of synthetic tyrosinase inhibitors possessing heterocyclic moieties reported within the last five years. For the reader's convenience, we classified them as inhibitors of mushroom tyrosinase (Agaricus bisporus) and human tyrosinase.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Monofenol Monooxigenasa / Compuestos Heterocíclicos Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Monofenol Monooxigenasa / Compuestos Heterocíclicos Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article